The therapeutic effect of combined cryotherapy, paramomycin, and intralesional meglumine antimoniate in treating lupoid leishmaniasis and chronic leishmaniasis

Abstract

International Journal of DermatologyVolume 45, Issue 8 p. 989-991 The therapeutic effect of combined cryotherapy, paramomycin, and intralesional meglumine antimoniate in treating lupoid leishmaniasis and chronic leishmaniasis M. A. Nilfrousihzadeh MD, M. A. Nilfrousihzadeh MD Skin Disease and Leishmaniasis Research Center (SDLRC) and Department of Pharmacology, Isfahan University of Medical Sciences and Health Services (IUMS), Sedigheh Tehareh Research Center, Isfahan, Iran E-mail: jaffary@pharm.mui.ac.irjaffary@interchange.ubc.caSearch for more papers by this authorF. Jaffray MD, PhD, F. Jaffray MD, PhD Skin Disease and Leishmaniasis Research Center (SDLRC) and Department of Pharmacology, Isfahan University of Medical Sciences and Health Services (IUMS), Sedigheh Tehareh Research Center, Isfahan, Iran E-mail: jaffary@pharm.mui.ac.irjaffary@interchange.ubc.caSearch for more papers by this authorM. R. Reiszadeh MD, M. R. Reiszadeh MD Skin Disease and Leishmaniasis Research Center (SDLRC) and Department of Pharmacology, Isfahan University of Medical Sciences and Health Services (IUMS), Sedigheh Tehareh Research Center, Isfahan, Iran E-mail: jaffary@pharm.mui.ac.irjaffary@interchange.ubc.caSearch for more papers by this authorN. Ansari MD, N. Ansari MD Skin Disease and Leishmaniasis Research Center (SDLRC) and Department of Pharmacology, Isfahan University of Medical Sciences and Health Services (IUMS), Sedigheh Tehareh Research Center, Isfahan, Iran E-mail: jaffary@pharm.mui.ac.irjaffary@interchange.ubc.caSearch for more papers by this author M. A. Nilfrousihzadeh MD, M. A. Nilfrousihzadeh MD Skin Disease and Leishmaniasis Research Center (SDLRC) and Department of Pharmacology, Isfahan University of Medical Sciences and Health Services (IUMS), Sedigheh Tehareh Research Center, Isfahan, Iran E-mail: jaffary@pharm.mui.ac.irjaffary@interchange.ubc.caSearch for more papers by this authorF. Jaffray MD, PhD, F. Jaffray MD, PhD Skin Disease and Leishmaniasis Research Center (SDLRC) and Department of Pharmacology, Isfahan University of Medical Sciences and Health Services (IUMS), Sedigheh Tehareh Research Center, Isfahan, Iran E-mail: jaffary@pharm.mui.ac.irjaffary@interchange.ubc.caSearch for more papers by this authorM. R. Reiszadeh MD, M. R. Reiszadeh MD Skin Disease and Leishmaniasis Research Center (SDLRC) and Department of Pharmacology, Isfahan University of Medical Sciences and Health Services (IUMS), Sedigheh Tehareh Research Center, Isfahan, Iran E-mail: jaffary@pharm.mui.ac.irjaffary@interchange.ubc.caSearch for more papers by this authorN. Ansari MD, N. Ansari MD Skin Disease and Leishmaniasis Research Center (SDLRC) and Department of Pharmacology, Isfahan University of Medical Sciences and Health Services (IUMS), Sedigheh Tehareh Research Center, Isfahan, Iran E-mail: jaffary@pharm.mui.ac.irjaffary@interchange.ubc.caSearch for more papers by this author First published: 17 January 2006 https://doi.org/10.1111/j.1365-4632.2006.02748.xCitations: 9Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume45, Issue8August 2006Pages 989-991 RelatedInformation